Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Jun Ho Yi; Seok Jin Kim; Dok Hyun Yoon; Cheolwon Suh; Myung Hee Chang; Deok Hwan Yang; Jae Cheol Jo; Shin Young Hyun; Hyeon Seok Eom; Jeong Ok Lee; Ji Hyun Kwon; Sang Hoon Han; Seung Shin Lee; Jae Yong Kwak; Se Hyung Kim; Dae Sik Kim; Ji Hyun Lee; Sung Yong Oh; Hun Mo Ryoo; Hyo Jung Kim; Won Seog Kim

doi:10.1002/cac2.12150

Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Jun Ho Yi
, Seok Jin Kim
, Dok Hyun Yoon
, Cheolwon Suh
, Myung Hee Chang
, Deok Hwan Yang
, Jae Cheol Jo
, Shin Young Hyun
, Hyeon Seok Eom
, Jeong Ok Lee
, Ji Hyun Kwon
, Sang Hoon Han
, Seung Shin Lee
, Jae Yong Kwak
, Se Hyung Kim
, Dae Sik Kim
, Ji Hyun Lee
, Sung Yong Oh
, Hun Mo Ryoo
, Hyo Jung Kim

Won Seog Kim^*

^*Corresponding author for this work

Department of Medicine

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	275-278
Number of pages	4
Journal	Cancer Communications
Volume	41
Issue number	3
DOIs	https://doi.org/10.1002/cac2.12150
State	Published - 2021.03

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/cac2.12150

Cite this

Yi, J. H., Kim, S. J., Yoon, D. H., Suh, C., Chang, M. H., Yang, D. H., Jo, J. C., Hyun, S. Y., Eom, H. S., Lee, J. O., Kwon, J. H., Han, S. H., Lee, S. S., Kwak, J. Y., Kim, S. H., Kim, D. S., Lee, J. H., Oh, S. Y., Ryoo, H. M., ... Kim, W. S. (2021). Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis. Cancer Communications, 41(3), 275-278. https://doi.org/10.1002/cac2.12150

@article{b40a21409193473297d36161e34aeb9d,

title = "Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis",

author = "Yi, \{Jun Ho\} and Kim, \{Seok Jin\} and Yoon, \{Dok Hyun\} and Cheolwon Suh and Chang, \{Myung Hee\} and Yang, \{Deok Hwan\} and Jo, \{Jae Cheol\} and Hyun, \{Shin Young\} and Eom, \{Hyeon Seok\} and Lee, \{Jeong Ok\} and Kwon, \{Ji Hyun\} and Han, \{Sang Hoon\} and Lee, \{Seung Shin\} and Kwak, \{Jae Yong\} and Kim, \{Se Hyung\} and Kim, \{Dae Sik\} and Lee, \{Ji Hyun\} and Oh, \{Sung Yong\} and Ryoo, \{Hun Mo\} and Kim, \{Hyo Jung\} and Kim, \{Won Seog\}",

year = "2021",

month = mar,

doi = "10.1002/cac2.12150",

language = "English",

volume = "41",

pages = "275--278",

journal = "Cancer Communications",

issn = "2523-3548",

number = "3",

}

Yi, JH, Kim, SJ, Yoon, DH, Suh, C, Chang, MH, Yang, DH, Jo, JC, Hyun, SY, Eom, HS, Lee, JO, Kwon, JH, Han, SH, Lee, SS, Kwak, JY, Kim, SH, Kim, DS, Lee, JH, Oh, SY, Ryoo, HM, Kim, HJ & Kim, WS 2021, 'Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis', Cancer Communications, vol. 41, no. 3, pp. 275-278. https://doi.org/10.1002/cac2.12150

TY - JOUR

T1 - Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma

T2 - a multicenter, retrospective analysis

AU - Yi, Jun Ho

AU - Kim, Seok Jin

AU - Yoon, Dok Hyun

AU - Suh, Cheolwon

AU - Chang, Myung Hee

AU - Yang, Deok Hwan

AU - Jo, Jae Cheol

AU - Hyun, Shin Young

AU - Eom, Hyeon Seok

AU - Lee, Jeong Ok

AU - Kwon, Ji Hyun

AU - Han, Sang Hoon

AU - Lee, Seung Shin

AU - Kwak, Jae Yong

AU - Kim, Se Hyung

AU - Kim, Dae Sik

AU - Lee, Ji Hyun

AU - Oh, Sung Yong

AU - Ryoo, Hun Mo

AU - Kim, Hyo Jung

AU - Kim, Won Seog

PY - 2021/3

Y1 - 2021/3

UR - https://www.scopus.com/pages/publications/85101544932

U2 - 10.1002/cac2.12150

DO - 10.1002/cac2.12150

M3 - Letter

C2 - 33626235

AN - SCOPUS:85101544932

SN - 2523-3548

VL - 41

SP - 275

EP - 278

JO - Cancer Communications

JF - Cancer Communications

IS - 3

ER -

Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

UN SDGs

Access to Document

Other files and links

Cite this